Resources/
Phil Blog
Phil Blog
5 Trends Set to Impact Patient Access to Prescription Therapy in 2024
The pharmaceutical industry finds itself at the crossroads of innovative treatments and technological advancements redefining how patients access prescribed therapy. However, this tremendous innovation has also presented unique challenges in securing patient affordability and access to therapy. These five key trends should be considered and will influence how manufacturers should think about shaping their services programs heading into 2024
Is your Patient Access Hub a Strategic Partner?
By Kelly Green, Vice President of Client Success at Phil, Inc. For patients prescribed a specialty or specialty-lite medication, getting started and staying on that therapy is typically a complex and expensive journey. That’s why many life science brands are increasingly turning to hub providers to support patient access and affordability
Digital Health’s Role in Transforming How Healthcare is Delivered
Editor’s Note: As the healthcare ecosystem continues to undergo significant digital transformations, life sciences companies would be wise to consider the impact of this evolution on one of their most important stakeholders - health care providers (HCPs). The fusion of the increased prevalence of blended care models, staff shortages, and higher utilization management requirements have resulted in an environment where HCPs find themselves more constrained than ever. This has made it more challenging for life sciences companies to effectively engage providers to ensure that patients can access their therapies
How Life Sciences Manufacturers can Meet HCP Expectations for Patient Access Support
With payer cost-containment measures continuing to escalate, patient access is top-of-mind for healthcare providers (HCPs) when deciding on prescribed therapy for their patients. Manufacturer-sponsored patient support programs are essential to helping patients get started and afford specialty and specialty-lite medications. A survey of 1,000 physicians found that HCPs believe these programs significantly positively impact their ability to practice medicine – yet, only 60% felt the pharmaceutical industry has robust patient support services
Enhancing your Patient Access Hub to Drive Brand Success
By Catherine Wood Hill, Vice President of Marketing at Phil, Inc. Biopharma hubs should strive to ensure patients get access to the medications they need quickly and affordably, while easing the manual effort required by prescribers. A positive hub experience builds trust, promotes brand loyalty, and supports ongoing therapy adherence
Ready to learn more?
Our consultants will work with you to analyze your current channel strategy and make recommendations for how to improve patient access and increase the percentage of scripts getting covered by insurance.
